Companies / Fennec Pharmaceuticals Inc. / Activity
Activity — Fennec Pharmaceuticals Inc.
78 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Raykov Rosty Director | Grant | Common shares | $0 | +5K +6.72% | 82,734 0.24% of shares | low |
| Feb 28, 2026 | Andrade Robert Executive | Grant | Common shares | $0 | +1K +0.49% | 243,584 0.70% of shares | low |
| Feb 18, 2026 | Andrade Robert Executive | Exercise | Common shares | $0 | +27K +12.68% | 242,393 0.70% of shares | low |
| Jan 31, 2026 | Andrade Robert Executive | Grant | Common shares | $0 | +2K +0.74% | 212,658 0.61% of shares | low |
| Dec 31, 2025 | Andrade Robert Executive | Grant | Common shares | $0 | +1K +0.79% | 176,916 0.51% of shares | low |
| Feb 18, 2026 | Hackman Jeffrey S. CEO | Exercise | Common Shares | $0 | +14K +91.40% | 28,710 0.08% of shares | low |
| Jun 10, 2026 | Cook Jodi A Director | Grant | Stock Options | — | +20K +14.29% | 160,000 0.46% of shares | low |
| Jun 10, 2026 | Islam Khalid Director | Grant | Stock Option | — | +25K +11.11% | 250,000 0.72% of shares | low |
| Jun 10, 2026 | Brughera Marco Maria Director | Grant | Stock Option | — | +20K +9.28% | 235,545 0.68% of shares | low |
| Jun 1, 2026 | Raykov Rosty Director | Exercise | Stock Options | — | -16K -0.99% | 1,556,195 4.48% of shares | low |
| May 1, 2026 | Raykov Rosty Director | Exercise | Stock Options | — | -16K -0.98% | 1,571,792 4.52% of shares | low |
| Mar 31, 2026 | Cioffi Christiana Marie Executive | Grant | Stock Options | — | +120K +82.59% | 265,300 0.76% of shares | low |
| Mar 31, 2026 | Sayad Pierre Sargis Executive | Grant | Stock Options | — | +120K +80.00% | 270,000 0.78% of shares | low |
| Mar 31, 2026 | Evans Terry L Executive | Grant | Stock Options | — | +120K +80.00% | 270,000 0.78% of shares | low |
| Mar 31, 2026 | Hackman Jeffrey S. CEO | Grant | Stock Options | — | +200K +38.10% | 725,000 2.09% of shares | low |
| Apr 1, 2026 | Raykov Rosty Director | Exercise | Stock Options | — | -16K -0.97% | 1,587,390 4.57% of shares | low |
| Mar 31, 2026 | Andrade Robert Executive | Grant | Stock Options | — | +120K +14.98% | 921,045 2.65% of shares | low |
| Jun 10, 2026 | Rallis Chris a Director | Grant | Stock Option | — | +20K +11.11% | 200,000 0.58% of shares | low |
| May 11, 2026 | Rallis Chris a Director | Exercise | Stock Option | — | -14K -7.15% | 186,189 0.54% of shares | low |
| Mar 2, 2026 | Raykov Rosty Director | Exercise | Stock Options | — | -16K -0.97% | 1,587,390 4.57% of shares | low |
| Feb 2, 2026 | Raykov Rosty Director | Exercise | Stock Options | — | -16K -0.96% | 1,602,988 4.61% of shares | low |
| Jan 2, 2026 | Raykov Rosty Director | Exercise | Stock Options | — | -16K -0.95% | 1,618,586 4.66% of shares | low |
| Mar 26, 2026 | Andrade Robert Executive | Exercise | Stock Options | — | -13K -1.61% | 801,045 2.31% of shares | low |
| Feb 18, 2026 | Andrade Robert Executive | Exercise | Stock Options | — | -2K -0.30% | 814,117 2.34% of shares | low |
| Jan 23, 2026 | Andrade Robert Executive | Exercise | Stock Options | — | -10K -1.21% | 816,567 2.35% of shares | low |
| Jan 15, 2026 | Andrade Robert Executive | Exercise | Stock Options | — | -10K -1.20% | 826,567 2.38% of shares | low |
| Jan 7, 2026 | Andrade Robert Executive | Exercise | Stock Options | — | -14K -1.67% | 836,567 2.41% of shares | low |
| Mar 26, 2026 | Cioffi Christiana Marie Executive | Exercise | Stock Options | — | -5K -3.13% | 145,300 0.42% of shares | low |